Stone Diagnostics Announces Strategic Partnership With Altus Ace (ACE)
Stone Diagnostics’ State-of-the-Art Preventive Diagnostic Testing Platforms Empower ACE Providers to Optimize Patient Outcomes With Preventative Diagnostic Testing Solutions
SANTA ROSA BEACH, FL & HOUSTON, TX / ACCESSWIRE / February 29, 2024 / Altus Ace (ACE), a frontrunner among accountable care organizations (ACOs) in the United States, proudly announces a pivotal strategic alliance with Stone Diagnostics, a premier provider of laboratory services nationwide. This collaboration marks a significant step forward in enhancing preventive care initiatives, underscoring ACE’s commitment to innovation and patient-centric healthcare solutions.
Stone Diagnostics will furnish ACE physicians and patients with comprehensive, end-to-end preventive care laboratory testing services. Renowned for its operational excellence and state-of-the-art preventive diagnostic testing platforms, Stone Diagnostics is poised to play a vital role in empowering ACE providers to deliver unparalleled care while optimizing patient outcomes.
“We are thrilled to embark on this transformative journey with Stone Diagnostics, elevating the standard of testing services for our esteemed provider and patient community,” remarked ACE CEO Rick Click. “True dedication to preventive care demands access to cutting-edge testing methodologies and intuitive features, and this partnership ensures that hundreds of our physicians managing thousands of patients receive just that.”
This strategic collaboration equips ACE with a robust Laboratory Operations Platform, renowned for its comprehensiveness, efficiency, reproducibility, and scalability – indispensable qualities in meeting escalating demands. By enabling ACE to streamline operations and focus steadfastly on the evolving needs of prescribers and patients alike, this partnership underscores ACE’s unwavering commitment to delivering best-in-class care and customer support.
Christopher Ridgeway, founder and CEO of Stone Diagnostics, echoed the sentiment, stating, “Stone Diagnostics stands at the forefront of in-network diagnostic companies, driven by a steadfast commitment to preventive care diagnostics and boutique-style customer service. Our alignment with ACE heralds a new era of growth and innovation in the diagnostics market, positioning us uniquely to capitalize on opportunities across infectious disease, pharmacogenetics, urine drug monitoring, chemistry, and hematology platforms.”
ACE’s national footprint extends its reach in providing accountable care and patient management services to payers nationwide. Leveraging advanced data analytics, ACE identifies medically necessary testing and proactively addresses chronic conditions to mitigate larger medical events, thereby reducing the overall cost of care.
By integrating data analytics with clinical diagnostics, ACE champions a proactive approach to healthcare, preempting medical events and fostering a culture of wellness and cost-efficiency.
Contact Information:
Christopher Ridgeway
CEO and Founder
cridgeway@stonediagnostics.com
5042599377
SOURCE: Stone Diagnostics
View the original press release on newswire.com.
